|
Journal of Cancer Research and Therapeutics
Medknow Publications on behalf of the Association of Radiation Oncologists of India (AROI)
ISSN: 0973-1482
EISSN: 0973-1482
Vol. 6, No. 3, 2010, pp. 344-346
|
Bioline Code: cr10082
Full paper language: English
Document type: Case Report
Document available free of charge
|
|
|
Journal of Cancer Research and Therapeutics, Vol. 6, No. 3, 2010, pp. 344-346
| en |
Rituximab-induced subacute interstitial pneumonitis: A case report and review of literature
Subramanian, Murali; Manjunath, R.; Kilara, Nalini & Mohan Rao, K. N.
Abstract
Rituximab is a chimeric anti-CD20 monoclonal antibody used to treat CD20+ non-Hodgkin′s lymphoma (NHL). Some pulmonary adverse reactions such as cough, rhinitis, bronchospasm and dyspnea are relatively common. Severe respiratory conditions like cryptogenic organizing pneumonia, interstitial pneumonitis have rarely been reported. We present a case of interstitial pneumonitis in a patient who was treated with R-CHOP for extranodal NHL. He responded to the steroids.
Keywords
Interstitial pneumonitis, non-Hodgkin′s lymphoma, Rituximab
|
| |
© Copyright 2010 Journal of Cancer Research and Therapeutics.
Alternative site location: http://www.cancerjournal.net/
|
|
